Raymond James Maintains Outperform on Omega Healthcare Invts, Raises Price Target to $36
Portfolio Pulse from Benzinga Newsdesk
Raymond James analyst Jonathan Hughes maintains an Outperform rating on Omega Healthcare Invts (NYSE:OHI) and raises the price target from $33 to $36.
September 20, 2023 | 11:26 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Omega Healthcare Invts' price target has been raised from $33 to $36 by Raymond James, maintaining an Outperform rating.
The raised price target and maintained Outperform rating by Raymond James indicates a positive outlook for Omega Healthcare Invts. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100